Health & Safety National More and more older Americans want to know their Alzheimer's status, survey finds 6:00am April 30, 2025 A survey of 1,700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's disease.
Health & Safety Science FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations 6:59pm June 10, 2024 by Jon Hamilton Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.
Science Health & Safety An experimental Alzheimer's drug outperforms one just approved by the FDA 4:33pm July 17, 2023 by Jon Hamilton In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.